Dr. Heather Lau: Gaucher and COVID-19
![Dr. Heather Lau: Gaucher and COVID-19](https://d3wo5wojvuv7l.cloudfront.net/t_square_limited_480/images.spreaker.com/original/795a2e07a692dd8c060854da9aa27236.jpg)
Regístrate gratis
Escucha este episodio y muchos más. ¡Disfruta de los mejores podcasts en Spreaker!
Descarga y escucha en cualquier lugar
Descarga tus episodios favoritos y disfrútalos, ¡dondequiera que estés! Regístrate o inicia sesión ahora para acceder a la escucha sin conexión.
Descripción
Heather Lau, MD, Director, Lysosomal Storage Disease Program at NYU Langone Health provides an overview of how to manage a person with Gaucher disease during the current COVID-19 pandemic. Gaucher...
mostra másGaucher disease is a genetic disorder in which glucocerebroside accumulates in cells and certain organs. The disorder is characterized by bruising, fatigue, anemia, low blood platelet count and enlargement of the liver and spleen.
Many Gaucher disease symptoms, comorbidities, and treatment options can complicate how these patients are managed during the current pandemic.
In this webinar, Dr. Lau explains the:
• Multisystemic manifestations of COVID-19
• Impact of COVID-19 on Gaucher
• Impact of Covid-19 on access to therapy
• Exposure to COVID-19. What to do?
• Ethical considerations of COVID-19 in Gaucher disease patients
To learn more about Gaucher disease and other lysosomal storage disorders, visit https://checkrare.com/gaucher-disease/ or https://www.gaucherdisease.org/
Información
Autor | Peter Ciszewski, CheckRare |
Página web | - |
Etiquetas |
Copyright 2024 - Spreaker Inc. an iHeartMedia Company